AVIRAGEN THERAPEUTICS INC's ticker is AVIR and the CUSIP is 053761102. A total of 34 filers reported holding AVIRAGEN THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $74,000 | – | 107,636 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SENZAR ASSET MANAGEMENT, LLC | 2,034,576 | $2,848,406,000 | 0.62% |
| Broadfin Capital, LLC | 3,486,711 | $4,881,000 | 0.48% |
| Stonepine Capital Management, LLC | 294,269 | $412,000 | 0.42% |
| TOWERVIEW LLC | 160,000 | $224,000 | 0.10% |
| BVF INC/IL | 208,353 | $292,000 | 0.06% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 224,477 | $314,000 | 0.04% |
| EAGLE GLOBAL ADVISORS LLC | 272,072 | $381,000 | 0.01% |
| JW Asset Management, LLC | 8,611 | $12,000 | 0.01% |
| Spark Investment Management LLC | 54,000 | $75,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 214,470 | $300,000 | 0.01% |